Neurobiology of Aging
Volume 32, Issue 4 , Pages 604-613 , April 2011

Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease

  • Emily R. Rosario

      Affiliations

    • Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, United States
    • ,
  • Lilly Chang

      Affiliations

    • Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, United States
    • ,
  • Elizabeth H. Head

      Affiliations

    • Department of Neurology, University of California Irvine, Irvine, CA 92697, United States
    • ,
  • Frank Z. Stanczyk

      Affiliations

    • Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, United States
    • ,
  • Christian J. Pike

      Affiliations

    • Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, United States
    • Corresponding Author InformationCorresponding author at: Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089-0191, United States. Tel.: +1 213 740 4205; fax: +1 213 740 4787.

Received 2 September 2008 ,Revised 21 March 2009 ,Accepted 10 April 2009.

References 

  1. Almeida TA, Papadopoulos N. Progression model of prostate cancer. Methods Mol. Biol. 2003;222:211–222
  2. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech. Ageing Dev. 1999;107(2):123–136
  3. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.). 1991;82(4):239–259
  4. Brinton RD. Impact of estrogen therapy on Alzheimer's disease: a fork in the road?. CNS Drugs. 2004;18(7):405–422
  5. Burger H, de Laet CE, van Daele PL, Weel AE, Witteman JC, Hofman A, et al. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am. J. Epidemiol. 1998;147(9):871–879
  6. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J. Neurosci. 2007;27(48):13357–13365
  7. Cherrier MM, Matsumoto AM, Amory JK, Asthana S, Bremner W, Peskind ER, et al. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology. 2005;64(12):2063–2068
  8. Cholerton B, Gleason CE, Baker LD, Asthana S. Estrogen and Alzheimer's disease: the story so far. Drugs Aging. 2002;19(6):405–427
  9. Cunningham CJ, Sinnott M, Denihan A, Rowan M, Walsh JB, O’Moore R, et al. Endogenous sex hormone levels in postmenopausal women with Alzheimer's disease. J. Clin. Endocrinol. Metab. 2001;86(3):1099–1103
  10. Das P, Howard V, Loosbrock N, Dickson D, Murphy MP, Golde TE. Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma−/− knock-out mice. J. Neurosci. 2003;23(24):8532–8538
  11. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291(24):2959–2968
  12. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262(18):2551–2556
  13. Gandy S, Almeida OP, Fonte J, Lim D, Waterrus A, Spry N, et al. Chemical andropause and amyloid-beta peptide. JAMA. 2001;285(17):2195–2196
  14. Gillett MJ, Martins RN, Clarnette RM, Chubb SA, Bruce DG, Yeap BB. Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia. J. Alzheimers Dis. 2003;5(4):267–269
  15. Goebelesmann U, Bernstein GS, Gale JA. Serum gonadotropin testosterone, estradiol, and estrone levels prior to and following bilateral vasectomy. In:  Lepow IH,  Crozier R editor. Vasectomy: Immunologic and Patholphysiologic Effects in Animals and man. New York, NY: Academic Press; 1979;p. 165
  16. Gouras GK, Xu H, Gross RS, Greenfield JP, Hai B, Wang R, et al. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc. Natl. Acad. Sci. U.S.A. 2000;97(3):1202–1205
  17. Hammond GL, Hirvonen J, Vihko R. Progesterone, Androstenedione, Testosterone, 5a-dihydrotestosterone and androsterone concentrations in specific regions of the human brain. J. Steroid Biochem. 1983;18(2):185–189
  18. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J. Clin. Endocrinol. Metab. 2001;86(2):724–731
  19. Henderson VW. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience. 2006;138(3):1031–1039
  20. Hogervorst E, Combrinck M, Smith AD. Testosterone and gonadotropin levels in men with dementia. Neuroendocrinol. Lett. 2003;24(3–4):203–208
  21. Hogervorst E, Bandelow S, Combrinck M, Smith AD. Low free testosterone is an independent risk factor for Alzheimer's disease. Exp. Gerontol. 2004;39(11–12):1633–1639
  22. Hogervorst E, Williams J, Budge M, Barnetson L, Combrinck M, Smith AD. Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinol. Lett. 2001;22(3):163–168
  23. Hogervorst E, Williams J, Combrinck M, Smith AD. Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur. J. Endocrinol. 2003;148(1):67–72
  24. Janowsky JS. Thinking with your gonads: testosterone and cognition. Trends Cogn. Sci. 2006;10(2):77–82
  25. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 1987;76(5):465–479
  26. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 2005;26(6):833–876
  27. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997;48(6):1517–1521
  28. Kleerekoper M, Sullivan JM. Osteoporosis as a model for the long-term clinical consequences of the menopause. Prog. Cardiovasc. Dis. 1995;38(3):181–188
  29. Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, Smith TE, et al. Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat. Med. 2005;11:545–550
  30. Lanthier A, Patwardhan VV. Sex steroids and 5-en-3 beta-hydroxysteroids in specific regions of the human brain and cranial nerves. J. Steroid Biochem. 1986;25(3):445–449
  31. Leranth C, Petnehazy O, MacLusky NJ. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J. Neurosci. 2003;23(5):1588–1592
  32. Manly JJ, Merchant CA, Jacobs DM, Small SA, Bell K, Ferin M, et al. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology. 2000;54(4):833–837
  33. Manni A, Pardridge WM, Cefalu W, Nisula BC, Bardin CW, Santner SJ, et al. Bioavailability of albumin-bound testosterone. J. Clin. Endocrinol. Metab. 1985;61(4):705–710
  34. McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, et al. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005;47(2):191–199
  35. Meador-Woodruff JH, Greden JF. Effects of psychotropic medications on hypothalamic-pituitary-adrenal regulation. Endocrinol. Metab. Clin. N. Am. 1988;17(1):225–234
  36. Melcangi RC, Panzica GC. Neuroactive steroids: old players in a new game. Neuroscience. 2006;138(3):733–739
  37. Militello A, Vitello G, Lunetta C, Toscano A, Maiorana G, Piccoli T, et al. The serum level of free testosterone is reduced in amyotrophic lateral sclerosis. J. Neurol. Sci. 2002;195(1):67–70
  38. Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188–193
  39. Morley JE. Androgens and aging. Maturitas. 2001;38(1):61–71
  40. Morley JE, Kaiser FE, Perry HM, Patrick P, Morley PM, Stauber PM, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997;46(4):410–413
  41. Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE, van der Schouw YT. Endogenous sex hormones in men aged 40–80 years. Eur. J. Endocrinol. 2003;149(6):583–589
  42. Nistor M, Don M, Parekh M, Sarsoza F, Goodus M, Lopez GE, et al. Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain. Neurobiol. Aging. 2007;28(10):1493–1506
  43. Paoletti AM, Congia S, Lello S, Tedde D, Orru M, Pistis M, et al. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology. 2004;62(2):301–303
  44. Petanceska SS, Nagy V, Frail D, Gandy S. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Exp. Gerontol. 2000;35(9–10):1317–1325
  45. Pike CJ, Nguyen TV, Ramsden M, Yao M, Murphy MP, Rosario ER. Androgen cell signaling pathways involved in neuroprotective actions. Horm. Behav. 2008;53(5):693–705
  46. Pike CJ, Rosario ER, Nguyen TV. Androgens, aging, and Alzheimer's disease. Endocrine. 2006;29(2):233–241
  47. Purifoy FE, Koopmans LH, Mayes DM. Age differences in serum androgen levels in normal adult males. Hum. Biol. 1981;53(4):499–511
  48. Ramsden M, Nyborg AC, Murphy MP, Chang L, Stanczyk FZ, Golde TE, et al. Androgens modulate beta-amyloid levels in male rat brain. J. Neurochem. 2003;87(4):1052–1055
  49. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2663–2672
  50. Rasmuson S, Nasman B, Carlstrom K, Olsson T. Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease. Dementia Geriatric Cogn. Disord. 2002;13(2):74–79
  51. Ravaglia G, Forti P, Maioli F, Bastagli L, Montesi F, Pisacane N, et al. Endogenous sex hormones as risk factors for dementia in elderly men and women. J. Gerontol. A Biol. Sci. Med. Sci. 2007;62(9):1035–1041
  52. Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 2002;23(3):279–302
  53. Rocca WA, Amaducci LA, Schoenberg BS. Epidemiology of clinically diagnosed Alzheimer's disease. Ann. Neurol. 1986;19(5):415–424
  54. Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J. Neurosci. 2006;26(51):13384–13389
  55. Rosario ER, Chang L, Stanczyk FZ, Pike CJ. Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004;292(12):1431–1432
  56. Rosario ER, Pike CJ. Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease. Brain Res. Rev. 2008;57(2):444–453
  57. Schumacher M, Guennoun R, Robert F, Carelli C, Gago N, Ghoumari A, et al. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm. IGF Res. 2004;14(Suppl A):S18–S33
  58. Schupf N, Winsten S, Patel B, Pang D, Ferin M, Zigman WB, et al. Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome. Neurosci. Lett. 2006;406(3):298–302
  59. Seftel AD. Male hypogonadism. Part I: Epidemiology of hypogonadism. Int. J. Impotence Res. 2006;18(2):115–120
  60. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291(24):2947–2958
  61. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2651–2662
  62. Stampfer MJ, Colditz GA, Willett WC. Menopause and heart disease. A review. Ann. N. Y. Acad. Sci. 1990;592:193–203
  63. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. Eur. J. Endocrinol./Eur. Federat. Endocr. Soc. 2001;145(6):669–679
  64. Tan RS, Pu SJ. Impact of obesity on hypogonadism in the andropause. Int. J. Androl. 2002;25(4):195–201
  65. Twist SJ, Taylor GA, Weddell A, Weightman DR, Edwardson JA, Morris CM. Brain oestradiol and testosterone levels in Alzheimer's disease. Neurosci. Lett. 2000;286(1):1–4
  66. Vermeulen A, Kaufman JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J. Clin. Endocrinol. Metab. 1996;81(5):1821–1826
  67. Watanabe T, Koba S, Kawamura M, Itokawa M, Idei T, Nakagawa Y, et al. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism. 2004;53(4):476–482
  68. Wise PM. Estrogen therapy: does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience. 2006;138(3):831–835
  69. Woolley CS. Effects of estrogen in the CNS. Curr. Opin. Neurobiol. 1999;9(3):349–354
  70. Yao M, Nguyen TV, Rosario ER, Ramsden M, Pike CJ. Androgens regulate neprilysin expression: role in reducing beta-amyloid levels. J. Neurochem. 2008;105:2477–2488
  71. Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, et al. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. U.S.A. 2005;102(52):19198–19203
  72. Zandi PP, Breitner JC. Estrogen replacement and risk of Alzheimer disease. JAMA. 2003;289(9):1100–1102
  73. Zandi PP, Carlson MC, Plassman BL, Welsh_Bohmer KA, Mayer LS, Steffens DC, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA. 2002;288(17):2123–2129

PII: S0197-4580(09)00123-7

doi: 10.1016/j.neurobiolaging.2009.04.008

Neurobiology of Aging
Volume 32, Issue 4 , Pages 604-613 , April 2011

Article Tools

* Image Usage & Resolution